Chemoinformaics analysis of 2-Methyl-2-phytyl-6-chromanol
| Molecular Weight | 388.636 | nRot | 12 |
| Heavy Atom Molecular Weight | 344.284 | nRig | 36 |
| Exact Molecular Weight | 388.334 | nRing | 2 |
| Solubility: LogS | -6.807 | nHRing | 1 |
| Solubility: LogP | 5.293 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 74.3629 |
| nHD | 1 | BPOL | 45.8771 |
| QED | 0.24 |
| Synth | 3.703 |
| Natural Product Likeliness | 0.989 |
| NR-PPAR-gamma | 0.965 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.143 |
| Pgp-sub | 0.001 |
| HIA | 0.277 |
| CACO-2 | -5.359 |
| MDCK | 0.0000138 |
| BBB | 0.006 |
| PPB | 0.987288 |
| VDSS | 0.377 |
| FU | 0.0173095 |
| CYP1A2-inh | 0.305 |
| CYP1A2-sub | 0.616 |
| CYP2c19-inh | 0.968 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.933 |
| CYP2c9-sub | 0.967 |
| CYP2d6-inh | 0.089 |
| CYP2d6-sub | 0.826 |
| CYP3a4-inh | 0.574 |
| CYP3a4-sub | 0.161 |
| CL | 11.424 |
| T12 | 0.196 |
| hERG | 0.061 |
| Ames | 0.673 |
| ROA | 0.968 |
| SkinSen | 0.932 |
| Carcinogencity | 0.233 |
| EI | 0.891 |
| Respiratory | 0.681 |
| NR-Aromatase | 0.419 |
| Antiviral | No |
| Prediction | 0.586355 |